Company / Current Assets
Nurix Therapeutics, Inc. Current Assets History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$606.8M
FY2025
5-year range
$295.5M / $619.4M
FY2021-FY2025
Trend
-2.0%
vs FY2024
Sector context
#98 of 213
Health Care
What the data says
At $607M, Nurix Therapeutics, Inc.'s current assets ranks #98 of 213 in the Health Care sector. Current Assets has fluctuated over the past 7 years, ranging from $39M in FY2019 to $619M in FY2024.
Based on SEC 10-K filings.
$607M in FY2025 with a 5-year CAGR of +15.3%.
Improved from $296M to $607M over the past 2 years.
Health Care sector context is included.
Current Assets over time
Growth rates
- 3-Year CAGR
- +24.0%
- 5-Year CAGR
- +15.3%
- 10-Year CAGR
- -
Sector benchmark
#98 of 213 in Health CareTop 46% of 213This company $606.8M Sector average $2.5B
▼
-75.9% below sector average
Key checks
Key Insights
- 5-year CAGR of +15.3%, indicating consistent growth.
- In FY2025, current assets decreased 2.0% year-over-year.
- Ranks #98 out of 213 companies in the Health Care sector.
- Peak current assets was recorded in FY2024.
Company context
Key Data Points
- Altman Z-Score -0.35 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $606.8M | -2.0% |
| FY2024 | $619.4M | +109.6% |
| FY2023 | $295.5M | -7.2% |
| FY2022 | $318.4M | +2.4% |
| FY2021 | $311.1M | +4.3% |
| FY2020 | $298.4M | +658.3% |
| FY2019 | $39.4M | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026